A concise methodology for the synthesis of (-)-Δ9-tetrahydrocannabinol and (-)-Δ9-tetrahydrocannabivarin metabolites and their regiospecifically deuterated analogs

Tetrahedron

Volumn 63, Issue 34, 2007, Pages 8112-8123

  Nikas, Spyros P ^a   Thakur, Ganesh A ^a   Parrish, Damon ^b   Alapafuja, Shakiru O ^a   Huestis, Marilyn A ^c   Makriyannis, Alexandros ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

^b NAVAL RESEARCH LABORATORY   (United States)

^c Intramural Research Program   (United States)

Author keywords

( ) 9 Tetrahydrocannabinol; ( ) 9 Tetrahydrocannabivarin; Metabolites; Regiospecifically deuterated analogs; Shapiro reaction

Indexed keywords

CANNABINOL DERIVATIVE; CARBOXYL GROUP; HYDROXYL GROUP; RESORCINOL DERIVATIVE; TETRAHYDROCANNABINOL; TETRAHYDROCANNABIVARIN; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL REACTION; METHODOLOGY; OXIDATION; PRIORITY JOURNAL; PURIFICATION; SHAPIRO REACTION; SYNTHESIS;

EID: 34447252632     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2007.06.006     Document Type: Article

References (58)

1. Razdan R.K., Uliss D.B., and Dalzell H.C. J. Am. Chem. Soc. 95 (1973) 2361-2362
2. Pitt C.G., Fowler M.S., Sathe S., Srivastava S.C., and Williams D.L. J. Am. Chem. Soc. 97 (1975) 3798-3802
3. Pitt C.G., Hobbs D.T., Schran H., Twine Jr. C.E., and Williams D.L. J. Labelled Compd. Radiopharm. 11 (1975) 551-575
4. Mechoulam R., Ben Zvi Z., Agurell S., Nilsson I.M., Nilsson J.L.G., Edery H., and Grunfeld Y. Experientia 29 (1973) 1193-1195
5. Wall M.E., and Perez-Reyes M. J. Clin. Pharmacol. 21 (1981) 178-189
6. Hawks, R. L. In NIDA Research Monograph Series: Hawks, R. L., Ed.; National Institute of Drug Abuse: Rockville, 1982; Vol. 42, pp 125-137.
7. Whiting J.D., and Manders W.W. J. Anal. Toxicol. 6 (1982) 49-52
8. Baker T.S., Harry J.V., Russell J.W., and Myers R.L. J. Anal. Toxicol. 8 (1984) 255-259
9. Law B., Mason P.A., Moffat A.C., Gleadle R.I., and King L.J. J. Pharm. Pharmacol. 36 (1984) 289-294
10. ElSohly M.A., Stanford D.F., and Little Jr. T.L. J. Anal. Toxicol. 12 (1988) 54-55
11. Tius M.A., Gu X.Q., and Kerr M.A. J. Chem. Soc., Chem. Commun. (1989) 62-63
12. Tius M.A., and Gu X. J. Chem. Soc., Chem. Commun. (1989) 1171-1173
13. Huffman J.W., Zhang X., Wu M.J., and Joyner H.H. J. Org. Chem. 54 (1989) 4741-4743
14. Tius M.A., and Kannangara G.S.K. J. Org. Chem. 55 (1990) 5711-5714
15. Huffman J.W., Zhang X., Wu M.J., Joyner H.H., and Pennington W.T. J. Org. Chem. 56 (1991) 1481-1489
16. Baek S.H., Szirmai M., and Halldin M.M. Pharmacol., Biochem. Behav. 40 (1991) 487-489
17. Seltzman H.H., Begum M.K., and Wyrick C.D. J. Labelled Compd. Radiopharm. 29 (1991) 1009-1018
18. Siegel C., Gordon P.M., Uliss D.B., Handrick G.R., Dalzell H.C., and Razdan R.K. J. Org. Chem. 56 (1991) 6865-6872
19. Siegel C., Gordon P.M., and Razdan R.K. Synthesis (1991) 851-853
20. Szirmai M., Halldin M.M., and Ohlsson A. J. Labelled Compd. Radiopharm. 31 (1992) 131-142
21. Tius M.A., and Kannangara G.S.K. Tetrahedron 48 (1992) 9173-9186
22. Feng S., and ElSohly M.A. J. Labelled Compd. Radiopharm. 43 (2000) 655-662
23. 11.
24. Nikas S.P., Thakur G.A., and Makriyannis A. Synth. Commun. 32 (2002) 1751-1756
25. Nikas S.P., Thakur G.A., and Makriyannis A. J. Chem. Soc., Perkin Trans. 1 (2002) 2544-2548
26. Nikas S.P., Thakur G.A., and Makriyannis A. J. Labelled Compd. Radiopharm. 45 (2002) 1065-1076
27. Uliss D.B., Handrick G.R., Dalzell H.C., and Razdan R.K. J. Am. Chem. Soc. 100 (1978) 2929-2930
28. Rickards R.W., and Watson W.P. J. Org. Chem. 45 (1980) 751-752
29. Kachensky D.F., and Hui R.A.H.F. J. Org. Chem. 62 (1997) 7065-7068
30. Pop E., Rachwal B., Rachwal S., Vlasak J., Brewster M.E., and Prokai L. J. Labelled Compd. Radiopharm. 41 (1998) 885-897
31. Siegel C., Gordon P.M., and Razdan R.K. J. Org. Chem. 54 (1989) 5428-5430
32. Razdan R.K., Dalzell H.C., and Handrick G.R. J. Am. Chem. Soc. 96 (1974) 5860-5865
33. Tius M.A., and Kerr M.A. Synth. Commun. 18 (1988) 1905-1911
34. Fahrenholtz K.E., Lurie M., and Kierstead R.W. J. Am. Chem. Soc. 89 (1967) 5934-5941
35. Archer R.A., Blanchard W.B., Day W.A., Johnson D.W., Lavagnino E.R., Ryan C.W., and Baldwin J.E. J. Org. Chem. 42 (1977) 2277-2284
36. Drake D.J., Jensen R.S., Busch-Petersen J., Kawakami J.K., Fernandez-Garcia M.C., Fan P., Makriyannis A., and Tius M.A. J. Med. Chem. 41 (1998) 3596-3608
37. Makriyannis, A.; Nikas, S. P.; Khanolkar, A. D. Application: WO 03005960, University of Connecticut, USA, 2003; p 53.
38. Huffman J.W., Joyner H.H., Lee M.D., Jordan R.D., and Pennington W.T. J. Org. Chem. 56 (1991) 2081-2086
39. Coxon J.M., Garland R.P., and Hartshorn M.P. Aust. J. Chem. 23 (1970) 1069-1071
40. Grimshaw J., Grimshaw J.T., and Juneja H.R. J. Chem. Soc., Perkin Trans. 1 (1972) 50-52
41. (1R)-(+)-Nopinone of high optical purity is commercially available or it can be synthesized by ozonolysis of commercially available (-)-β-pinene.
42. Van De Water R.W., Hoarau C., and Pettus T.R.R. Tetrahedron Lett. 44 (2003) 5109-5113
43. Kim S., Wu J.Y., Zhang Z., Tang W., Doss G.A., Dean B.J., DiNinno F., and Hammond M.L. Org. Lett. 7 (2005) 411-414
44. 1H NMR analysis (500 MHz).
45. Mechoulam R., Braun P., and Gaoni Y. J. Am. Chem. Soc. 94 (1972) 6159-6165
46. Adlington R.M., and Barrett A.G.M. Acc. Chem. Res. 16 (1983) 55-59
47. Chamberlin A.R., and Bloom S.H. Org. React. 39 (1990) 1-83
48. Solvents such as ethanol, hexane, diethyl ether and a range of temperatures (-10 to 45 °C) were used with or without the presence of molecular sieves or catalytic amounts of HCl.
49. Nikas, S. P.; Makriyannis, A. Unpublished results.
50. Arndt F. Org. Synth. XV (1935) 3-5
51. Wilson R.S., and May E.L. J. Med. Chem. 18 (1975) 700-703
52. Wilson R.S., and May E.L. J. Med. Chem. 17 (1974) 475-476
53. Bruker. SMART v5.625 (2001), Bruker AXS, Madison, WI
54. Bruker. SAINT v6.36A (2002), Bruker AXS, Madison, WI
55. Bruker. XPREP v6.12 (2001), Bruker AXS, Madison, WI
56. Bruker. SADABS v2.03 (2000), Bruker AXS, Madison, WI
57. Bruker. SHELXTL v6.14 (2000), Bruker AXS, Madison, WI
58. Flack H.D. Acta Crystallogr., Sect. A 39 (1983) 876-881